# SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction

Study · id `cardio:ct-nct05583773` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05583773](<https://clinicaltrials.gov/study/NCT05583773>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05583773

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 336 participants.

## Technical summary

Registry record NCT05583773. Randomized; double masking; primary purpose treatment. Start 2023-03-29 (actual); primary completion 2027-03-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 336 participants (planned count; ClinicalTrials.gov record NCT05583773, source copy `cardio:ctgov-nct05583773-2026-11-05`, retrieved 2026-11-18)
- Started: 2023-03-29 (actual) (ClinicalTrials.gov record NCT05583773, source copy `cardio:ctgov-nct05583773-2026-11-05`, retrieved 2026-11-18)
- Primary completion: 2027-03-31 (anticipated) (ClinicalTrials.gov record NCT05583773, source copy `cardio:ctgov-nct05583773-2026-11-05`, retrieved 2026-11-18)
- Completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT05583773, source copy `cardio:ctgov-nct05583773-2026-11-05`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT05583773, source copy `cardio:ctgov-nct05583773-2026-11-05`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05583773-2026-11-05`, retrieved 2026-11-18)

## The registry's words

- Brief title: SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction
- Acronym: SHINE-HF
- Condition: Heart Failure
- Intervention (Drug): ShengXian-QuYu Decoction
- Intervention (Other): Placebo
- Lead sponsor: China-Japan Friendship Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: China-Japan Friendship Hospital (`cardio:org-china-japan-friendship-hospital`)

## Provenance

Content hash: 0bb73d6cacd0309ba16de4929196c446f01625585033f618417c16123b360afd
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
